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ABSTRACT
Intracellular bacterial pathogens in the family Chlamydiaceae are causes of human blindness, sexually transmitted disease, and
pneumonia. Genetic dissection of the mechanisms of chlamydial pathogenicity has been hindered by multiple limitations, in-
cluding the inability to inactivate genes that would prevent the production of elementary bodies. Many genes are also Chlamyd-
ia-specific genes, and chlamydial genomes have undergone extensive reductive evolution, so functions often cannot be inferred
from homologs in other organisms. Conditional mutants have been used to study essential genes of manymicroorganisms, so we
screened a library of 4,184 ethyl methanesulfonate-mutagenized Chlamydia trachomatis isolates for temperature-sensitive (TS)
mutants that developed normally at physiological temperature (37°C) but not at nonphysiological temperatures. Heat-sensitive
TSmutants were identified at a high frequency, while cold-sensitive mutants were less common. Twelve TSmutants were
mapped using a novel markerless recombination approach, PCR, and genome sequencing. TS alleles of genes that play essential
roles in other bacteria and chlamydia-specific open reading frames (ORFs) of unknown function were identified. Temperature-
shift assays determined that phenotypes of the mutants manifested at distinct points in the developmental cycle. Genome se-
quencing of a larger population of TSmutants also revealed that the screen had not reached saturation. In summary, we describe
the first approach for studying essential chlamydial genes and broadly applicable strategies for genetic mapping in Chlamydia
spp. andmutants that both define checkpoints and provide insights into the biology of the chlamydial developmental cycle.
IMPORTANCE
Study of the pathogenesis of Chlamydia spp. has historically been hampered by a lack of genetic tools. Although there has been
recent progress in chlamydial genetics, the existing approaches have limitations for the study of the genes that mediate growth of
these organisms in cell culture. We used a genetic screen to identify conditional Chlamydiamutants and thenmapped these al-
leles using a broadly applicable recombination strategy. Phenotypes of the mutants provide fundamental insights into unex-
plored areas of chlamydial pathogenesis and intracellular biology. Finally, the reagents and approaches we describe are powerful
resources for the investigation of these organisms.
Chlamydiae are obligate intracellular pathogens that share acharacteristic biphasic developmental cycle where these or-
ganisms alternate between extracellular, infectious elementary
body (EB) and intracellular, replicative reticulate body (RB) forms
(1).Multiple species of the familyChlamydiaceae, includingChla-
mydia trachomatis,C. pneumoniae, andC. psittaci, are common or
incidental pathogens of humans (2). Despite their medical im-
portance, a lack of tools for genetic manipulation of these or-
ganisms was a major impediment in chlamydial research until
recently (3, 4).
Only 60% of Chlamydiaceae genes share significant homol-
ogy with genes of other organisms, and many of these conserved
genes mediate essential processes in other bacteria (5). Ancient
divergence of Chlamydia from other bacterial phyla also allowed
high proportions of Chlamydia-specific open reading frames
(cORFs) to arise in an otherwise-conserved genome (6). System-
level searches for essential Chlamydia genes have not been re-
ported, but results of three recent studies provide data similar to
data that have been used in genetic footprinting analyses for iden-
tification of essential genes in other microorganisms (7, 8). Ap-
proximately 1.3% of the mutations identified in predicted coding
ORFs of a population of 934 randomly selected ethyl methanesul-
fonate (EMS)-mutagenized C. trachomatis isolates were nonsense
mutations (9). In contrast, when nonessential C. trachomatis (10)
and C. muridarum (11) genes were sequenced in similarly mu-
tagenized libraries,5% of the mutations led to the formation of
nonsense codons, consistent with the mutational spectrum of
EMS-induced mutations in Escherichia coli (12). Overall, these
observations suggest that a significant proportion of C. trachoma-
tis genes are essential in cell culture.
Tools for genetic modification of Chlamydia spp., including
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mutagenesis coupled with forward and reverse genetic analyses
(10, 11, 13), intraspecies and interspecies lateral gene transfer
(LGT) (14–16), transformation (17), targeted disruption of genes
using type II introns (18, 19), and deletion of genes by allelic
exchange (20), have been reported, but all have limitations for the
study of genes that impact chlamydial fitness in cell culture (3, 21).
Another group attempted to identify the lethal temperature-sen-
sitive (TS) allele in a C. abortusmutant isolated from a chemically
mutagenized library by comparing the genome of that mutant to
that of its parent (22, 23). Twenty-two mutations were identified,
but theTS phenotypewas not linked to any specificmutation (23).
Here we tested the possibility of using conditional mutants to
identify genes that mediate C. trachomatis survival in cell culture.
We describe straightforward approaches for isolating conditional
mutants and broadly applicable methods for mapping detrimen-
tal Chlamydia alleles in natural chlamydial variants and mutants
identified in genetic screens. Finally, we identify multiple genes
that mediate growth of these organisms in cell culture.
MATERIALS AND METHODS
Cell lines and strains. McCoy and HeLa 229 (HeLa) cells were obtained
from theAmericanTypeCultureCollection andweremaintained in high-
glucose Dulbecco’s modified Eagle’s medium (DMEM) (HyClone) sup-
plemented with nonessential amino acids, HEPES, and 10% fetal bovine
serum (Atlanta Biologicals) (DMEM-10). C. trachomatis L2-434/Bu (L2)
was transformedwith the green fluorescent protein (GFP)-encoding plas-
mid pGFP::SW2 as described previously (17). The resulting strain (L2-
GFP) was plaque purified (24) twice prior to being mutagenized for con-
struction of libraries.
Mutant library construction. McCoy cell monolayers were infected
with L2-GFP at a multiplicity of infection (MOI) of 2 by rocking as de-
scribed previously (25). Chlamydia cells were mutagenized by adding 10
ml of ethyl methanesulfonate (EMS) (4 mg/ml) to the infection medium
at 18 h postinfection (hpi), using a method similar to one we described
previously (11). Mutagenized EBs were harvested from the cells by me-
chanical disruption at 34 hpi. Mutants were isolated from EB stocks by
plaque cloning and were arrayed in cell culture plates. Plaques were ex-
panded in McCoy cells for 70 h. Expanded library plates were stored at
80°C.
Temperature sensitivity screen.HeLa cells were infected with library
isolates by centrifugation followed by rocking at 37°C for 30 min. Repli-
cate plates were incubated at 32°C, 37°C, or 40°C. Monolayers were fixed
at 34 hpi (for 37°C or 40°C plates) or at 58 hpi (for 32°C plates) with 3.7%
formaldehyde. Chlamydial inclusions were imaged at 4 magnification
using an EVOS fluorescence microscope and counted using a custom
macro in FIJI (26). Ratios of inclusion-forming units of individual library
isolates at permissive temperature versus nonpermissive temperature
were then calculated. Isolates that had fold change values of 15 were
rescreened to confirm their phenotypes. Mutants were plaque cloned
twice and expanded in flasks. EBs were released from host cells by bead
agitation in sucrose-phosphate-glutamic acid buffer (SPG), and host cell
debris was removed by centrifugation at 500 g for 20min before storage
at80°C. Selected mutants (see Fig. 3) were purified over 30% MD-76R
as described by Rajaram et al. (11).
Temperature shift assays.HeLa cells were infected at anMOI of 0.1 as
described above. For HS mutants, experimental plates were incubated at
40°C and thenmoved to 37°C as indicated. Control plates were incubated
at 37°C. Cold-sensitive (CS) mutants were incubated at 37°C and then
moved to 32°C at the times indicated. The infected cells were fixed at 34
hpi (37°C and 40°C) or 58 hpi (32°C) and labeled with a chlamydial
lipopolysaccharide (LPS)-specific monoclonal antibody (EVI-H1) and a
secondary fluorophore-conjugated antibody. Inclusions were imaged
at 10 magnification on an EVOS fluorescence microscope (Thermo
Scientific). Inclusion cross-sectional areas were measured in CellProfiler
(27) using a modified pipeline (28). Mutants were sorted into develop-
mental cycle classes based on the first time interval during which their
mean normalized inclusion area was80% of that measured for L2-GFP.
Equal adjustments to brightness and contrast of images were made in
Adobe Photoshop CS6.
Sequencing library construction and whole-genome sequencing.
Genomeswere sequenced using two strategies. For some isolates, genomic
DNA from 30% MD-76R-purified and DNase-treated EBs (29) was
treated with NEBNext double-stranded DNA (dsDNA) Fragmentase
(NEB) to generate dsDNA formultiplex Illumina sequencing according to
the protocols of the manufacturer (Illumina). A TruSeq Nano DNA sam-
ple preparation kit was used to prepare DNA sequencing libraries. Sam-
ples weremultiplexed using TruSeq single-index sequencing primers, and
paired-end 100-bp sequencing was performed at the Tufts University
Genomics Core Facility in Boston, MA, on an Illumina HiSeq 2500 sys-
tem. For other isolates, whole-genome amplification was performed on
crude EB preparations using a REPLI-g kit (Qiagen) as described in ref-
erence 30, excluding the immunomagnetic cell separation step. These
libraries were prepared using a NexteraXT DNA library preparation kit
according to the instructions of the manufacturer (lllumina). Samples
were multiplexed using a NexteraXT dual-index primer kit, and single-
end 100-bp sequencing was performed at the Oregon State University
Center for Genomic Research and Biocomputing Core Sequencing Facil-
ity (Corvallis, OR) on an Illumina HiSeq 2000 system.
Genome assembly and sequence analysis. Sequence data generated
from the TruSeqNano library were analyzed as described previously (11).
Assembly of genome sequences for the NexteraXT library was performed
using an alternate workflowmethod (30) with the additional use of ad hoc
Python scripts and the Geneious sequence manipulation software suite
(version 7) (31) (see Tables S1 and S2 in the supplemental material).
Ambiguous sequences from the data set and mutation calls with low-
quality scores were resolved by Sanger sequencing. PCR primers are listed
in Table S3.
Markerless recombination. HeLa cells were coinfected with pairs of
HS or CSmutants with each parent at anMOI of 2, incubated at 37°C, and
then harvested at 34 hpi by freeze-thaw in SPG and bead agitation. The
harvests were passaged in a blind manner in HeLa cells grown at a non-
permissive temperature and were harvested at 34 hpi, after which the
passage and harvest steps were repeated. Recombinants were isolated by
limiting dilution, rescreened to confirm temperature resistance, subjected
to plaque cloning, and expanded. Genomic DNA was isolated by alkaline
lysis. Sanger sequencing was used to determine which single nucleotide
polymorphisms (SNPs) present in the parents were retained in the prog-
eny (see Table S2 in the supplemental material).
Statistics. Fold changes of mutant phenotypes at permissive versus
nonpermissive temperatures were normalized to fold changes of L2-GFP
phenotypes at the same temperatures. Data were subjected to log trans-
formation and analyzed by one-way analysis of variance (ANOVA) with a
Dunnett’s posttest to detect differences where the P value was 0.05
(GraphPad Prism version 6.0).
RESULTS
Screen for C. trachomatis TS mutants. Parallel screens were de-
veloped for cold-sensitive (CS) and heat-sensitive (HS) Chla-
mydia TSmutants (Fig. 1A). L2-GFP was mutagenized with EMS,
and 4,184 mutant plaques were expanded in McCoy cells. Equal
volumes of each isolate were used to infect parallel wells of HeLa
cells in three plates, which were then incubated at the permissive
(37°C) or nonpermissive (32°C or 40°C) temperature. Approxi-
mately 3% of the library isolates were HS in the primary screen,
which we defined as isolates that formed 15-fold or greater ratios
of GFP-positive (GFP) inclusions at 37°C compared to 40°C
(Fig. 1B). Five CS isolates which formed 15-fold or greater ratios
of inclusions at 37°C compared to 32°C were also identified. To
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confirm phenotypes of the mutants identified in the primary
screen, we next performed a more stringent secondary screen
where we additionally controlled for differences in the ability of
L2-GFP to form inclusions at different temperatures. For the HS
mutants, we compared the ratios of inclusions that each of the
mutants formed at 37°C compared to 40°C to the ratio of the
inclusions that L2-GFP formed at the same two temperatures.
Similarly, we compared the ratio of inclusions that theCSmutants
formed at 37°C versus 32°C to the ratio of inclusions that L2-GFP
formed at the same two temperatures. This allowed us to focus
subsequent efforts on 26 HS and 2 CS isolates that met the more
stringent criteria in that they formed15-fold ratios of inclusions
at the permissive compared to nonpermissive temperature after
normalization to L2-GFP (Fig. 1B). Four isolates that were both
CS andHS but which did not meet the stringency threshold in the
secondary screen were also characterized.
TS mutants are phenotypically diverse. We next performed
temporal heat shift assays to test if the TS isolates had similar
phenotypes. These assays were performed by shifting infections
between permissive and nonpermissive temperatures at various
intervals postinfection (Fig. 2A). Infections with the HS mutants
were initially incubated at 40°C and then were shifted to 37°C. In
contrast, CS mutants were initially incubated at 37°C and then
were shifted to 32°C. In both cases, the sizes of the inclusions
formed by the mutants in these assays were compared to those
seen with L2-GFP grown at the same temperature. Unique defects
of the TS mutants became apparent during different temperature
shift intervals, allowing them to be sorted into different temporal
classes (Fig. 2A and Table 1). We defined these intervals by iden-
tifying the earliest temperature shift timewhen the cross-sectional
area of themutant inclusions fell below 80%of the area of L2-GFP
inclusions grown under the same conditions. For example, the
cross-sectional area of HS1 inclusions decreased between 12 and
18 hpi when this isolate was incubated at 40°C (Fig. 2B). In con-
trast, the cross-sectional areas of L2-GFP, and of a recombinant
strain that we produced by crossing HS1 and HS13 (HS1HS13
[discussed below]), increased during the same interval (Fig. 2B).
These assays sorted the mutants into phenotypic classes corre-
sponding to the time during which their TS phenotypes were first
detected: prior to 12 hpi (early), 12 to 18 hpi (early-mid), 18 to 24
hpi (mid-late), or over 24 hpi (late) (Table 1). Notably, early-mid
and mid-late TS mutants were more abundant than late mutants,
consistent with the patterns of de novo gene expression in C. tra-
chomatis (32).
Next, we performed one-step growth curve analyses to com-
pare the burst sizes of representative TSmutants, selected from the
early, early-mid, and mid-late temperature shift classes, at both
their permissive andnonpermissive temperatures. Themajor pur-
pose of this was to quantify how the TS phenotypes impacted the
ability of the various mutants to produce infectious EBs. Most of
the mutants had burst sizes similar to those seen with L2-GFP at
37°C (Fig. 3A) but produced substantially fewer EBs at the restric-
tive temperatures (Fig. 3B) than did L2-GFP. The burst sizes of
other TS isolates whose phenotypes were eventually mapped to
specific alleles, discussed below, were also determined (see Fig. S1
in the supplemental material). Overall, the results of these exper-
iments indicated that most of the TS mutants had minor pheno-
types or no phenotype at 37°C but produced fewer infectious
progeny at nonpermissive temperatures.
Mutant genotyping.Genome sequencing determined that the
TS mutants contained an average of 6 mutations in total (range, 1
to 11), with an average of 4 nonsynonymous mutations in pre-
dicted coding ORFs (see Table S1 in the supplemental material).
Nonsynonymous mutations were detected in the same gene or
ORF in different mutants in 22 cases (2 to 4 occurrences). How-
ever, almost all of those mutations were unique, indicating that
our screen had not reached saturation. Only two nonsynonymous
mutations were identified in genes known to encode central com-
ponents of heat shock, cold shock, or stress responses in other
bacteria (DksAE61K and ObgEG92E), and no mutations were iden-
tified inChlamydia heat shock genes groEL, groES, and dnaK (33).
We could not specifically link dksA or obgE to temperature sensi-
tivity because the TS mutants that had these alleles also had other
mutations (see Table S1). These results showed that the TS phe-
notypes of most of themutants were not linked to canonical stress
response pathways.
Mapping TS alleles. All but one (HS17; RpsHA119V) of the TS
mutants contained multiple mutations, which prevented us from
linking specific mutations in these mutants to their phenotypes.
We next tested if it was possible to produce recombinants of TS
mutants by selecting against the parents using the nonpermissive
temperature. HS1, HS13, and HS23 were selected for proof-of-
principle experiments because these mutants had strong pheno-
types andmultiple mutations (10, 6, and 4, respectively) for mon-
itoring potential recombination events. Pairs of TS parents were
coinfected, and recombinant progeny were selected for by growth
at the nonpermissive temperature (40°C). Isolates from each cross
FIG 1 Temperature-sensitive (TS) screen. (A) Corresponding wells of three
separate plates of HeLa cells were infected with equal inoculums of isolates
fromanEMS-mutagenized L2-GFP library, and then the plateswere incubated
at different temperatures. Inclusions were counted at 34 hpi (37°C and 40°C
plates) or 58 hpi (32°C plates). IFU, inclusion-forming units. (B) Numbers of
temperature-sensitive isolates observed in the primary and secondary screens,
where temperature sensitivity was defined using different stringency thresh-
olds.
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were purified by limiting dilution, plaque cloned, and confirmed
to be temperature resistant (Fig. 4).
Targeted sequencing revealed that the isolates from both the
HS1HS13 and HS1HS23 crosses contained all of the muta-
tions present in HS1, with the exception of the allele encoding
GltXQ487*. This result was confirmed by genome sequencing of an
isolate from theHS1HS13 cross (Fig. 4B; see alsoTable S2 in the
supplemental material). Inclusion morphology and infectious
progeny production of the HS1HS13 recombinant were indis-
tinguishable from the results seen with L2-GFP and significantly
differed from the results seenwith both parent strains (Fig. 4C and
D). Since only the HS1 gltX allele segregated in this cross, it could
not be determined if this occurred via genetic reversion or recom-
bination. However, outgrowth of a population passaged at 40°C
was observed only in the wells containing both HS1 and HS13 or
HS1 andHS23 and not in control wells with an equal inoculum of
HS1 EBs (data not shown). Temperature-resistant progeny were
also not observed when 1.4  109 HS1 EBs were passaged in a
blind manner 5 times in HeLa cells at the nonpermissive temper-
ature (data not shown).
Twelve TS isolates were crossed and mapped using PCR, tar-
geted Sanger sequencing, and/or genome sequencing. Crosses
with multiple parents were required in some cases. The TS alleles
were mapped to a single mutant allele in 10 of the 12 strains and
were mapped to two closely linked mutant alleles in the other two
strains (Table 2; see also Table S2 in the supplemental material).
Many crosses produced mosaics, which we defined as strains that
contained at least twomutations from each of the parental strains,
in contrast to isogenic strains that differed from one of the parents
by only a single mutation (Fig. 4A). This confirmed that recom-
bination, and not reversion, was the predominant mechanism
involved in generation of temperature-resistant isolates from
temperature-sensitive parents. When isogenic progeny could
not be isolated, multiple mosaic progeny strains were used to
deduce the TS allele through phenotypic linkage as described
previously (13).
Four of the TS alleles corresponded to genes whose homologs
mediate essential processes in other bacteria, including DNA rep-
lication (dnaE), tRNA aminoacylation (gltX), proton gradient
generation (atpB), and translation (rpsH). Another TS allele
FIG 2 Phenotypes of the TS mutants manifest at different points in the developmental cycle. (A) HeLa cells were infected with L2-GFP or TS mutants and were
then incubated at 37°C or 40°C. Some infected cells initially incubated at 40°Cwere shifted to 37°C at various times postinfection. In all cases, the inclusions were
fixed and stained with anti-LPS antibody at 34 hpi. Representative images of early-, early-mid-, andmid-late-stagemutants are shown. Note that the average size
of HS1 (early) inclusions decreased dramatically between the 12-h and 18-h temperature shifts, whereas the average size of HS11 (mid-late) inclusions decreased
dramatically between the 18-h and 24-h shifts. (B) Comparison of the cross-sectional areas of L2-GFP, HS1, and HS1HS13 (a recombinant generated from
crossingHS1 andHS13) at 34 hpi following different temperature shift scenarios. Note that the cross-sectional areas of L2-GFP,HS1, andHS1HS13 inclusions
were similar at 34 hpi when the infections were shifted from 40°C to 37°C at 8 hpi and at 12 hpi but differed significantly when the temperature shift was
performed at 18 h postinfection or later.
TABLE 1 Phenotypic sorting of mutants by cross-sectional inclusion
areaa
Mutant
category
No. of isolates
Early
(0–12 hpi)
Early-mid
(12–18 hpi)
Mid-late
(18–24 hpi)
Late
(24 hpi)
HS 12 14 3 0
CS 4 0 0 2
a Dual HS/CS mutants were counted in both the HS and CS totals.
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mapped to fabI, which encodes the enoyl-acyl carrier protein for
type II fatty acid biosynthesis, which is essential for cellular repli-
cation in Chlamydia spp. (34). Finally, 4 alleles mapped to cORFs
(ctl0322, ctl0456, ctl0597, and ctl0681).
DISCUSSION
TS mutants can provide insights into poorly explored areas of
chlamydial biology that cannot be interrogated using existing
tools. For example, HS1 contains a nonsense mutation that trun-
cates glutamyl-tRNA synthetase (GltX), which is predicted to
aminoacylate both tRNAGlu and tRNAGln in Chlamydia spp. (35).
Interestingly, de novo translation of some immediate-early pro-
teins (36–38) precedes de novo transcription of tRNA, tRNAmod-
ification enzymes, and aminoacyl transferases in C. trachomatis,
including gltX, which is predicted to be transcribed at 8 hpi in C.
trachomatis serovar D (32). Transfer RNAs are abundant in C.
trachomatis EBs (54), although the aminoacylation status of these
is unknown. Proteomic studies (40–42) have also identified ami-
noacyl-tRNA synthetases in EBs. Since growth ofHS1was rescued
when this mutant was shifted from 40°C to 37°C as late as 18 hpi
(Fig. 3B), our results suggest that EBs may contain pools of ami-
noacylated-tRNAs or that tRNAs and functional GltX are pre-
loaded into EBs (Fig. 3B). In future work, we hope to test this
hypothesis by determining if EBs contain aminoacylated-tRNAGlu
and tRNAGln using denaturing acid gel electrophoresis andNorth-
ern blot analysis and methods similar to those described by Jester
et al. (43).
Chlamydia trachomatis encodes a truncated partial tricarbox-
ylic acid (TCA) cycle that cannot use pyruvate as an initial sub-
strate (9, 44). Despite this, Chlamydia trachomatis can import the
TCA intermediate 2-oxoglutarate (45). TwoCSmutants (CS1 and
CS3) had nonsense mutations in the putative dicarboxylate trans-
porter CTL0456 (SodTi), which is predicted to import 2-oxoglu-
tarate to feed the TCA cycle (46). Both nonsense mutations trun-
cate the protein before the residues required by theVibrio cholerae
SodTi homolog to contact dicarboxylates (47), suggesting that the
truncated SodTi in CS1 and CS3 is nonfunctional. The TS allele in
HS20 also mapped to ctl0456. The CTL0456G145R missense muta-
tion inHS20 is proximal to the first Ser-Asn-Thrmotif that would
be predicted to contact the dicarboxylate ligand. C. trachomatis
encodes a putative glutamate transporter, GltT, from which
2-oxoglutarate could be generated from hydrolysis of glutamate
by glutamate dehydrogenase (46). However, a GltT nonsensemu-
tant is viable at 37°C (9). These observations suggest that 2-oxo-
glutarate acquisition is essential in C. trachomatis and that redun-
dant pathways for import of this substrate are available at
physiological temperatures. Comparing uptake of isotopically la-
beled 2-oxogluterate and glutamate in TCA mutants using ap-
proaches pioneered by the McClarty group (48) could elucidate
essential Chlamydia TCA cycle substrates.
Some of the TS mutants provide insight into potential func-
tions of cORFs. For example, Grieshaber et al. recently reported
that the noncoding RNA (ncRNA) IhtA interferes with the trans-
lation of the chlamydial histone-like protein HctA and CTL0322
(49). HctA functions similarly to a eukaryotic histone and medi-
ates condensation of chromatin during the RB-to-EB transition
(50–52). Like HctA, CTL0322 is predicted to be a small, highly
basic protein, and the C. trachomatis serovar D homolog of
CTL0322 is nucleotropic in Hep2 cells (53). Greishaber proposed
that, similarly to HctA, CTL0322 might bind DNA and mediate
the RB-to-EB transition (49). Supporting this hypothesis, HS11,
which contains CTL0322M51I, has a TS defect that initiates be-
tween 18 and 24 hpi, corresponding to the beginning of the RB-
to-EB transition in these strains of C. trachomatis.
Although our results suggest that the TS approach can identify
essential C. trachomatis genes, some limitations must be consid-
ered. Phenotypes of some of the TS alleles may not be directly
linked to thermal inactivation of their encoded proteins. For ex-
ample, we suspect that the nonsense alleles of ctl0456 in CS1 and
CS3 are nulls. Since many TS mutations are dominant, it also
cannot be immediately differentiated if TS alleles are cis-acting or
trans-acting. The TS alleles mapped in this study are not in known
ncRNA regions (54–56), and missense mutations usually do not
cause polar effects. Another limitation is that the phenotypes of
the TS mutants need to be compared to those of the correspond-
FIG3 TSmutants produce few infectious EBs at nonpermissive temperatures.
(A) Burst sizes were calculated by comparing the number of inclusions TS
isolates formed in primary infections to the number formed in secondary
infections performed with harvests from the primary infections. Most of the
mutants had burst sizes similar to those seen with L2-GFP at 37°C, although
the burst sizes of two of the CS mutants were significantly reduced. The mu-
tants are grouped by the temporal classes identified as described for Fig. 2 (A,
early; B, early-mid; C,mid-late). (B) Comparison of levels of EB production of
the TS mutants at permissive and nonpermissive temperatures. The numbers
of progeny produced byHSmutants at 37°C and 40°Cwere compared, and the
numbers of progeny of CS mutants were compared at 37°C and 32°C. This
ratio was then compared to the ratio of inclusions formed by L2-GFP at the
same two temperatures to determine the fold reduction. The experiments were
performed three times in triplicate, and error bars show standard deviations.
Mutants with results that differed from those determined for L2-GFP (P 
0.05) were identified by one-way ANOVA followed by Dunnett’s post hoc test
and are indicated by asterisks.
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ing non-TS parent at the same temperature becauseC. trachomatis
developmental kinetics differ at 32°C, 37°C, and 40°C.
TS alleles also have practical applications in genetic analysis.
Markerless recombination using TS alleles circumvents some lim-
itations of antibiotic-driven LGT (14, 15). Only a few endogenous
resistance alleles in Chlamydia spp. have been described, and use
of other resistance transgenes is contraindicated due to concerns
about clinical resistance. We identified TS alleles located across
FIG 4 Markerless recombination mapping of TS alleles. (A) Recombinants were generated by coinfecting HeLa cells with two different HS or CS parents and
selecting for temperature-resistant progeny at 40°C or 32°C as appropriate. Isogenic andmosaic recombinants resulted. (B) Alleles that differed in the parents of
a representative cross, indicated by colored rectangles, were sequenced. (C) Inclusion morphologies of L2-GFP, HS1, HS13, and a recombinant isolate derived
from crossingHS1 andHS13 (HS1HS13) at 37°C and 40°C, analyzed at 34 hpi. Inclusions were labeled with an anti-LPS antibody. (D) EB production of HS1,
HS13, andHS1HS13 at 37°C versus 40°C compared to that seen with L2-GFP. The graph showsmeans of results of 3 experiments performed in triplicate, and
the error bars indicate standard deviations. The HS strains produced significantly fewer EB at 40°C than at 37°C than did L2-GFP or recombinant HS1HS13
(*, P 0.05), whereas the levels of EB production seen with HS1HS13 and L2-GFP did not differ, as determined by one-way ANOVA followed by Dunnett’s
post hoc test. ns, not significant.
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the length of the C. trachomatis genome. Thus, fine segregation of
alleles is possible with the TS LGT strategy due to an abundance of
potential recombination partners. We have also observed that
both endogenous antibiotic resistance alleles and resistance trans-
genes can alter chlamydial growth rates and can yield synthetic
phenotypes when combined (data not shown), neither of which is
a limitation of ourmarkerless strategy. Another potential applica-
tion of TS alleles is in trans-acting and conditional counterselec-
tion. We have observed that some of the TS alleles are toxic when
expressed from the chlamydial plasmid at nonpermissive temper-
ature (data not shown). This suggests that these alleles could be
harnessed for genetic applications analogous to those employing
the lethal Escherichia coli sucrose sacB gene (57).
Overall, multiple characteristics of TS mutants make them
powerful tools for broader study of essential and pleiotropicChla-
mydia genes. First, since most TS mutations are missense muta-
tions, they are ideal for interrogation of essential genes in operons.
Second, we have isolated intragenic suppressors of one of the TS
mutants (HS23) by passage at nonpermissive temperature (data
not shown). This represents a powerful new tool for studying pro-
tein-protein interactions. Finally, our existing collection of TS
mutants defines a series of temporal checkpoints in the chlamydial
developmental cycle. These mutants could be especially useful for
ordering closely linked processes in chlamydial development and
could provide a mechanism to better understand the transcrip-
tome and proteome throughout development without the com-
plications of asynchrony.
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